Can Mounjaro Cause Urine Infections? What the Evidence Actually Shows

What SURMOUNT trial data and the SmPC actually record

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity over 72 weeks and captured side-effect data systematically across all dose groups. The adverse events that appeared consistently were gastrointestinal: nausea, vomiting, diarrhoea and constipation, typically peaking in the days after a dose step and settling as the body adjusted. Urinary tract infections did not emerge as a treatment-related finding in that cohort.

The NHS medicines page for tirzepatide reflects the same picture. The side effects listed there cover the GI-led profile, along with injection-site reactions, fatigue, dizziness and headache. A urine infection is not among them. The UK SmPC, which governs how Mounjaro is licensed and prescribed, similarly does not identify urinary tract infection as a recognised adverse reaction at any dose level.

That matters, because it means if you develop a urine infection while taking Mounjaro, the current evidence does not support tirzepatide as the cause, and our page covering Mounjaro and urine infections explains in more detail why the two so often coincide without one causing the other. It is more likely to be an unrelated infection, coinciding with your treatment period rather than caused by it.

Why people who take Mounjaro may still get urine infections

Mounjaro is licensed both for weight management and for type 2 diabetes. People with type 2 diabetes have a well-established, higher background risk of urinary tract infections regardless of which medicine they take. Elevated blood glucose encourages bacterial growth in the urinary tract, and that vulnerability does not disappear the moment treatment begins. For someone who was experiencing recurrent infections before starting Mounjaro, the pattern may simply continue.

There is also a separate, related question worth distinguishing: yeast infections, which behave differently from bacterial urine infections and are linked to different mechanisms. If that is the concern, the evidence on tirzepatide and yeast infections covers the relevant background in more detail.

A question our prescribers hear most weeks is whether a new symptom that appears after starting treatment must be caused by the medicine, and if you are wondering specifically whether Mounjaro can cause a water infection, the honest answer is that the evidence does not currently support that link. What matters is that any urinary symptoms are assessed by a healthcare professional rather than managed at home on the assumption that Mounjaro is to blame.

When urinary symptoms need medical attention

Whatever the cause, a urine infection that is left untreated can spread to the kidneys and become serious. The symptoms to act on promptly include a burning sensation when urinating, needing to go more frequently than usual, cloudy or strong-smelling urine, pain in the lower abdomen or lower back, and a fever or shivering. If any of these appear, contact your GP or call NHS 111 rather than waiting to see whether they resolve.

There is one additional consideration for people on Mounjaro specifically. Severe gastrointestinal side effects, particularly prolonged vomiting or diarrhoea at the start of treatment or after a dose increase, can cause dehydration. Dehydration is itself a risk factor for urinary tract infections and can also affect kidney function. Staying well hydrated is sensible throughout treatment, and if GI symptoms are severe enough to affect your fluid intake, that warrants a call to your prescriber or our aftercare team.

You can also report any suspected side effect, whether or not you are certain it is related to treatment, through the MHRA's Yellow Card scheme. That reporting system is how post-market safety signals are detected, and it is open to patients as well as clinicians.

What this means if you are considering Mounjaro for weight management

A history of recurrent urine infections is not a contraindication to tirzepatide, but it is information a prescriber needs. At nume, every consultation is read by a GPhC-registered independent prescriber who reviews your health history before any treatment is approved. If recurrent infections have been part of your picture, that context shapes the clinical decision. You can read more about how the process works, and what tirzepatide involves as a treatment, on our tirzepatide overview page.

For a broader look at Mounjaro's side-effect profile and what to expect in practice, the Mounjaro information page covers the full landscape. If you have a specific question about bladder symptoms rather than classic urine infections, the evidence on Mounjaro and bladder infections addresses that separately. And if you are ready to talk through your own circumstances with a prescriber, you can start your free consultation at any point.